Mathieu Flamini

The 10 Most Innovative Bioeconomy CEOs 2022. Now choose the number 1

Il BioeconomistaLeave a comment
wpid-20150618_135539.jpg
“Bioeconomy in everyday life” @ BioBased World 2015 in Frankfurt am Main

The circular bioeconomy is innovation, the result of the skills and passion of researchers and managers able to create value and new high-qualified jobs, reconciling economy, society and the environment. At the end of 2014 Il Bioeconomista launched a new initiative: The 10 Most Innovative Bioeconomy CEOs.

We have asked a panel of world bioeconomy experts to tell us the Chief Executive Officers that have stood out as the most innovative during the last year.

Now we ask you to choose the most innovative CEO responding to our survey (open till December 13 at 7 am, Western European Time).

The most innovative CEO 2016 was Ken Richards (CEO of Leaf Resources, Australia)

The most innovative CEO 2017 was Tony Duncan (CEO of Circa Group, Australia)

The most innovative CEO 2018 was Jürgen Eck (CEO of BRAIN AG, Germany)

The most innovative CEO 2019 was Alex Michine (CEO of MetGen, Finland)

The most innovative CEO 2020 was Simão Soares (CEO of SilicoLife, Portugal)

The most innovative CEO 2021 was Jennifer Holmgren (CEO of LanzaTech, USA)

This is the result of 2022 (in alphabetical order)

Catia Bastioli, Novamont (Italy)

Dominique Boies, Enerkem (Canada)

Mathieu Flamini, GFBiochemicals (France)

Jennifer Holmgren, LanzaTech (USA)

Philippe Lacamp, SkyNRG (The Netherlands)

Matt Lipscomb, DMC Biotechnologies (USA)

Eric A. McAfee, Aemetis (USA)

Christophe Schilling, Genomatica (USA)

Nicolas Sordet, Afyren (France)

Tom van Aken, Avantium (The Netherlands)

An exclusive interview with Mathieu Flamini, CEO GFBiochemicals: ”The road to sustainability and the fight against climate change is a road from which there is no turning back”

Il Bioeconomista1 Comment
1384FE6D-3D3E-466C-8036-C0D865392EB6
Mathieu Flamini, CEO GFBiochemicals. He played as a midfielder for Olympique de Marseille, Arsenal FC, AC Milan, Crystal Palace FC and Getafe Club de Fútbol. Picture: courtesy of Flamini

I met Mathieu Flamini in Milano during the Design Week. Milano is vibrant again after the dark years of the pandemic. AC Milan won the championship, eleven years after the last success of which Mathieu was one of the architects. We do not talk about football, also because I cheer for the other team based in Milano. I am totally black and blue and I can’t share his joy for the AC Milan’s Scudetto. We talk about the bioeconomy, starting from his new role as CEO of GFBiochemicals, which he is enthusiastic about. Mathieu is a friend, so I immediately declare that this is a somewhat unusual interview. With Mathieu we talk about the need to accelerate on the path of the paradigm shift that leads us from fossils to the use of renewable biological sources, the importance of communicating the damages produced by industrial activity on the environment in order to promote sustainable solutions, the role of the sport’s world in a campaign that highlights the contradictions of a development model based on profit at all costs and the waste of resources.

Interview by Mario Bonaccorso

Continue reading →

Pasquale Granata and Mathieu Flamini launch The BioJournal

Il Bioeconomista1 Comment

Mathieu Flamini and Pasquale Granata launch The BioJournal
Mathieu Flamini and Pasquale Granata launch The BioJournal

Published “to take part in a severe contest between intelligence, which presses forward, and an unworthy, timid ignorance obstructing our progress.”

We can borrow this mission statement written on the contents page of the first issue of The Economist, published by James Wilson in September 1843, to define exactly the reason that today, 173 years later, leads to the launch of The BioJournal.

Continue reading →

Arsenal midfielder Mathieu Flamini scores a goal in the bioeconomy

Il BioeconomistaLeave a comment

image
Mathieu Flamini

Former AC Milan and France midfielder Mathieu Flamini is a bioeconomy’s supporter. He has revealed that he is one of the people behind GFBiochemicals, a bio-based company that has developed a process to produce levulinic acid on an industrial scale.

Continue reading →